Niitaka (4465) Q1 2027 earnings summary

Executive summary

• Revenue increased 5.5% year-over-year to ¥6,334 million, driven by strong sales in detergents, solid fuels, and infection control products.

• Operating profit rose 0.5% to ¥585 million, while ordinary profit declined 1.2% to ¥608 million.

• Net income attributable to shareholders was ¥415 million, down 0.8% year-over-year.

• Profitability was maintained despite higher raw material costs and a decline in healthcare segment earnings, offset by expanded sales and price revisions in the chemical segment.

• The business environment showed moderate recovery in consumption and investment, but uncertainty persisted due to inflation, geopolitical risks, and market volatility.

Financial highlights

• Gross profit for the quarter was ¥2,315 million, with a gross margin of 36.6%.

• EPS for the quarter was ¥71.00, nearly flat year-over-year.

• Comprehensive income was ¥467 million, down 2.4% year-over-year.

• Total assets at quarter-end were ¥23,181 million, with net assets of ¥16,219 million.

• Net income attributable to shareholders was ¥415 million, down 0.8% year-over-year.

Outlook and guidance

• Full-year revenue is forecast at ¥27,500 million, up 11.7% year-over-year.

• Operating profit is projected at ¥1,800 million (down 15.0%), and net income at ¥1,285 million (down 32.4%).

• No changes have been made to previously announced guidance.